(NEW YORK)Shares of CombinatoRx Inc. crashed to an all-time low Monday after the biotech company said its lead drug candidate missed its main goal in clinical trial.READ MORE
(CAMBRIDGE, Mass.)The drug candidate Synavive missed its main goal in a clinical trial, developer CombinatoRx Inc. said Monday, as the drug did not significantly improve symptoms of osteoarthritis o...READ MORE
(CAMBRIDGE, Mass.)Biotech drug developer CombinatoRx Inc. said Wednesday its second-quarter loss widened as the company spent more money to develop its drug candidates Synavive and CRx-401 and reven...READ MORE